SciELO - Scientific Electronic Library Online

 
vol.25 issue1Productive parameters and digestibility of chickens, using cayenne (Hibiscus rosa-sinensis) and probiotic (Lactobacilius acidophilus) plus pectinAssessment of phenotypic variability in Simarouba amara Aubl., through qualitative and quantitative descriptors author indexsubject indexarticles search
Home Pagealphabetic serial listing  

Services on Demand

Journal

Article

Indicators

Related links

  • On index processCited by Google
  • Have no similar articlesSimilars in SciELO
  • On index processSimilars in Google

Share


ORINOQUIA

On-line version ISSN 0121-3709

Abstract

CUADROS-CORREDOR, Yesid L; SIABATO-MORENO, Juan C  and  ROQUE-RODRIGUEZ, Anita. Use of growth factors present in platelet-rich plasma as an alternative treatment for musculoskeletal lesions in animals. Orinoquia [online]. 2021, vol.25, n.1, pp.47-64.  Epub Nov 03, 2021. ISSN 0121-3709.  https://doi.org/10.22579/20112629.655.

A systematic review of platelet-rich plasma (PRP) use in animals was carried out by taking 105 reference articles published during the last 8 years (2012 to 2020) in Veterinary Medicine International, Scientific Reports, BMC Veterinary Research, Platelets, Biomedicine and Pharmacotherapy; they were validated in the following databases: PubMed, Web of Science, ScienceDirect, SciELO, Medline, Embase and Scopus. The search was limited to just journals having a high impact factor; the SCImago journal rank (SJR) indicator (i.e. a sophisticated citation analysis algorithm) was also used. Only 35 of these articles met the selection criteria: i.e. coordinating content with current needs in veterinary medicine, seeking new biotechnological approaches and promoting regenerative medicine based on reconstructing living tissue to counteract damage or replace injured organs’ function. One such tool is platelet-rich plasma (PRP) with its derivative growth factors (GF): transforming growth factor-ß (TGF-ß), basic fibroblast growth factor (bFGF), platelet-derived growth factor (PDGF), vascular endothelial growth factor (VEGF), connective tissue growth factor (CTGF) and epidermal growth factor (EGF). PRP is currently used as a biostimulant, acting as the basis for human and veterinary medicine studies; its effectiveness regarding bone/fracture healing/regeneration in clinical patients has been observed. Scientific evidence in the pertinent medical literature regarding PRP as an alternative treatment for managing fractures and musculoskeletal injuries was collected, thereby determining the importance of standardising the PRP procedure regarding its use, preparation, storage and administration.

Keywords : biotechnology; biostimulant; bone consolidation; osteoinductive fractures; platelet and plasma..

        · abstract in Spanish | Portuguese     · text in Spanish     · Spanish ( pdf )